1.2Lower peroxide concentration
A fitted tray holds the mixed gel against the tooth surfaces. Hydrogen peroxide oxidizes stain compounds during repeated applications.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A fitted tray holds the mixed gel against the tooth surfaces. Hydrogen peroxide oxidizes stain compounds during repeated applications.
Sodium acid pyrophosphate dissolves in the aqueous active component. Pyrophosphate binds trace metal ions that catalyze hydrogen peroxide decomposition during storage.
Dilute sulfuric acid sets an acidic pH for peroxide storage. A buffered thickening component adjusts the pH when the two components mix.
Dilution water passes through a chelating resin bed that captures dissolved iron and copper. The treated water is blended with high-purity peroxide concentrate in polymer equipment to limit metal contamination.
A porous polyethylene insert lines the tooth-facing surface of the tray. Capillary forces retain the liquid in the insert, and peroxide diffuses through the wetted pores to the tooth surface.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A dental materials laboratory uses the peroxide active component and aqueous acrylic thickener to treat stained enamel coupons held in a specimen rack. A removable mask defines an exposed window on each coupon, and a fixed-volume dispenser deposits freshly mixed gel into the window. A reflectance colorimeter measures each window before treatment and after the gel is rinsed away.
The thickening component contains hydroxyethyl cellulose dispersed and hydrated in water. A separate reservoir holds the hydrogen peroxide, sodium stannate, phosphoric acid, and EDTA solution. A metering head combines the two streams immediately before dispensing, and the hydrated cellulose gives the mixed gel its viscosity.
A bench dispenser holds the peroxide solution and acrylic thickener in separate reservoirs and uses two coupled positive displacement pumps to feed a static mixer. Three stroke settings deliver mixed volumes of 50, 100, or 200 microliters while maintaining the same component ratio. A rack holds three specimen sizes, and the operator selects the corresponding stroke setting before dispensing into a shallow well above each specimen.
A thermoformed dental tray incorporates shallow wells over the facial surfaces of selected teeth. A dual chamber cartridge feeds the peroxide solution and aqueous acrylic thickener into a disposable static mixer. The mixer outlet fills each well before tray placement, and raised borders around the wells confine the gel to the selected surfaces.
The peroxide solution and aqueous acrylic thickener are mixed at the outlet of a dual chamber dispenser and deposited on the exposed tooth surface. A disposable suction tip positioned next to the treated surface connects to a chairside vacuum line through a collection canister. The tip lifts the bulk gel first, then collects rinse water and residual gel as the surface is irrigated.
Two independently driven pumps feed the peroxide solution and aqueous acrylic thickener into a disposable mixing cup on a load cell. A controller tares the cup and meters each component sequentially until its programmed mass increment is reached. The controller checks both recorded increments against their tolerances before enabling a stirrer to blend the batch.
One chamber of a dual-barrel syringe holds the aqueous active component behind a separate piston. A common plunger drives both pistons and feeds the components into a static mixing tip.
An aqueous phosphoric acid stock is metered into the active component under agitation. A peroxide-compatible pH probe measures the batch after mixing and indicates when it reaches the specified storage pH.
Crosslinked polyacrylic acid powder disperses and hydrates in water. Partial neutralization converts carboxylic acid groups to carboxylate groups, causing the polymer network to swell and increase viscosity.
Water passes through mixed-bed ion exchange media to reduce dissolved ions. The treated water serves as the continuous phase in which the acrylic resin disperses and hydrates.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The preservative reagent comprises (i) polyethylene glycol (PEG), (ii) ethanol, (iii) paraformaldehyde (PFA), and (iv) ethylenediaminetetraacetic acid (EDTA).A · US 2019/0357523 A1 · ¶ 7
An amorphous form of a chelating agent is provided, in particular wherein the chelating agent comprises ethylenediaminetetraacetic acid/edetic acid (EDTA), diethylenetriaminepentaacetic acid/pentetic acid (DTPA), nitrilotriacetic acid (NTA), amino tris(methylenephosphonic acid) (ATMP), ethylenediamine tetramethylene phosphonic acid (EDTMP), 1-hydroxyethane 1,1-diphosphonic acid (HEDP), ethylenediaminedisuccinic acid (EDDS), iminodisuccinic acid (IDS), hydroxamic acid, oxalicB · US 2022/0002226 A1 · abstract
The preservative reagent may be prepared by individually dissolving each of PEG, PFA and EDTA in deionized water, and then mixing selected amounts of the solutions with ethanol.A · US 2019/0357523 A1 · ¶ 27
An empty cell means only that no passage was reproduced there.
As the results, there is a need for an effective preservative reagent that can stabilize tumor cells in urine specimen for the microfiltration.A · US 2019/0357523 A1 · ¶ 4
Upon addition to a urine sample, cells in the sample, such as tumor cells, remain in an unaltered state for a period of time sufficient to allow analysis of the sample and cells therein when convenient for the researcher or laboratory performing the analysis.A · US 2019/0357523 A1 · ¶ 6
Moreover, the amorphous particulates produced in accordance with the process of present invention present advantageous characteristics regarding particle size batch-to-batch consistency and solubility.B · US 2022/0002226 A1 · ¶ 2
These agents can be applied, for example, in the pharmaceutical field particularly in novel formulations having these excipients in the composition.B · US 2022/0002226 A1 · ¶ 2
patent.fyi, US 2026/0355078 A1, claim 1, first published 2026-11-19T07:53:10-05:00, https://patent.fyi/US20260355078/, SHA-256 4897e2481ab2384611225fb99f5647922b46f86ae9beae83f85422ed27c3e00c